Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.

Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.

Item

http://www.wikidata.org/entity/Q34504454

Q34504454

about

Citalopram versus other anti-depressive agents for depression Antidepressant drug effects and depression severity: a patient-level meta-analysis Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions.A comparison of patterns of spontaneous adverse drug reaction reporting with St. John's Wort and fluoxetine during the period 2000-2013.A systematic review of St. John's wort for major depressive disorder.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.Homeopathic Individualized Q-Potencies versus Fluoxetine for Moderate to Severe Depression: Double-Blind, Randomized Non-Inferiority Trial Comparative efficacy and risk of harms of immediate- versus extended-release second-generation antidepressants: a systematic review with network meta-analysis.Complementary and alternative medicine therapies to promote healthy moods A meta-analysis on the efficacy and safety of St John's wort extract in depression therapy in comparison with selective serotonin reuptake inhibitors in adults Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode - a subgroup analysis.Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials.Amended safety assessment of Hypericum perforatum-derived ingredients as used in cosmetics.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.The mu-opioid receptor agonist remifentanil induces acute dysphoria irrespective of its analgesic properties.Neurotrophic, Cytoprotective, and Anti-inflammatory Effects of St. John's Wort Extract on Differentiated Mouse Hippocampal HT-22 Neurons.

P2860

Q24202141-805A354F-D1FB-43F0-82F9-B36A929FF25A Q24598580-3FF34C83-FE64-4605-91FA-4F65ECD3BF6E Q34240696-23C8A971-7656-48B5-AA09-9412561E2C11 Q34360600-1160D5CC-8ED0-453C-93E4-31BE549D54C5 Q34476963-750F91A7-4C29-44F0-BD5D-630C39AC4F66 Q34539296-075E4A25-D34F-4D7D-BEBB-8C5C2D5EBCE5 Q34590507-C4C98BC6-1480-487E-A57B-127A81FE94B4 Q34707570-F354BBA4-F691-4252-AC5D-9E1335B2BA82 Q35105942-67365481-B0A3-4D96-A49C-F0D7BC3398DE Q35162633-15246C8F-2263-41A1-B86F-F0F319B5BC9F Q36579052-999C65EE-AC04-40AE-B39E-304583A07BBB Q37098635-E0DCE809-3367-47D0-91EA-9F27C800F480 Q37107406-3DA5A77B-BFFF-45A7-90E6-E3AA280FDC26 Q37948756-C6EB96F7-C8C1-422C-A047-7AE5983E950E Q38258277-4AC91396-6367-4EB7-B7AC-D4C2A82D5F96 Q38476909-C95D55A4-7445-4CC7-B9CB-17930F4E888A Q44340170-AFF0DBE6-8D10-4D8A-9E0D-0E789F13B140 Q49244418-3ACEB61E-A020-42F7-889E-DB60CA2726C5

P2860

Comparative efficacy and safety of a once-daily dosage of hypericum extract STW3-VI and citalopram in patients with moderate depression: a double-blind, randomised, multicentre, placebo-controlled study.

Item

http://www.wikidata.org/entity/Q34504454

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu